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Abstract 
A new assay for the production of reactive sulfhydryl-bearing antibody Fab' fragments has been utilized to develop conditions 
affording high efficiencies of coupling of mouse and rabbit IgG-derived Fab' fragments to lipid vesicles containing maleimidyl-func- 
tionalized phospholipids. Cysteine and mercaptoethylamine, but not dithiothreitol, reduce antibody F(ab') 2 to Fab' fragments in very good 
yields under conditions where overreduction to heavy and light chains is minimized. Surprisingly, however, a large fraction of the Fab' 
fragments generated under these conditions can lack maleimide-reactive sulfhydryl groups, as demonstrated using a maleimidyl-poly(eth- 
ylene glycol) conjugate to shift selectively the electrophoretic mobility of the reactive sulfhydryl-bearing Fab' fragments. After 
modification of F(ab') 2 reduction conditions pecifically to maximize the yield of the latter fraction, it is possible to achieve high and 
very reproducible coupling of functional Fab' fragments to liposomes (equivalent to coupling of ca. 70% of total input protein and almost 
100% of the reactive sulfhydryl-bearing Fab' fraction). A novel phospholipid-poly(ethylene glycol)-maleimide 'anchor' allows particu- 
larly efficient coupling of Fab' fragments to liposomes, even using relatively low liposome concentrations and molar percentages of the 
liposome-incorporated 'anchor' species. These results demonstrate that with appropriate optimization of the conditions for Fab' 
production and liposome coupling, Fab' fragments can be coupled to liposomes with efficiencies comparable to or exceeding those 
reported for coupling of intact antibodies. These results should facilitate the wider use of Fab' fragments as a potentially advantageous 
alternative to intact antibodies for liposomal targeting in various applications. 
Keywords: Liposome; Liposomal targeting; Antibody; Liposome-antibody conjugation; Poly(ethylene glycol)-modified lipid 
1. Introduction 
'Targeting' of liposomes via surface-coupled antibodies 
has proven an effective method to modify the biodistribu- 
Abbreviations: BMP-, N-(fl-maleimidopropionyl)-; BMPS, fl- 
maleimidopropionic acid N-l~ydroxysuccinimide ester; BSA, bovine 
serum albumin; CF, 5-(and-6)-earboxyfluorescein; DCCD, N,N'-dicyclo- 
hexylcarbodiimide; DMF, dimethylformamide; DTPA, diethylenetri- 
aminepentaacetic a id; DTr, dithiothreitol; EMC-, N-(e-maleimido- 
caproyl)-; EMCS, e-maleimidocaproic a id N-hydroxysuccinimide ester; 
ePC, egg phosphatidylcholine; PG, egg phosphatidylglycerol; 
HBSS/Hepes, Hank's balanced salt solution with 10 mM N-(2-hydroxy- 
ethyl)piperazine-N'-(2-ethanesulfonic acid) (pH 7.2); HOBT, N-hydroxy- 
benzotriazole; LUV, large unilamellar vesicle(s); Mops, 3-(N-morpho- 
lino)propanesulfonic a id; NEM, N-ethylmaleimide; PEG, poly(ethylene 
glycol); PDP-, N-(3-(2-pyridyldithio)propionyl)-; PE, phosphatidyl- 
ethanolamine; Rho-PE, N-lissamine rhodaminesulfonyl-PE; SUV, small 
unilamellar vesicle(s); TEA, triethylamine; Tes, N-tris(hydroxy- 
methyl)methyl-2-aminoethanesulfonic acid; TLC, thin-layer chromatog- 
raphy; tPE, transphosphatidylated eggphosphatidylethanolamine. 
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tion and/or  the pharmacokinetic behaviour of liposomes 
in various applications [1-8]. A variety of techniques has 
been proposed and exploited for the covalent coupling of 
antibodies to liposomes (for reviews see [9,10]). With few 
exceptions [10-12], an inherent feature of these ap- 
proaches is the largely nonselective modification of several 
amino acid residues per antibody molecule, an aspect of 
the methodology that, in at least some cases [13], is in fact 
required for optimal efficiency of antibody-liposome cou- 
pling. Such multiple and largely random modifications of 
the antibody molecules increase significantly the potential 
both for alteration of biological activity and, using some 
modifying agents, for the creation of neoepitopes [14] in a 
significant fraction of the antibody population. 
In principle, antibody Fab' fragments represent an at- 
tractive alternative to whole antibodies as liposomal target- 
ing agents for many applications. Fab' fragments can be 
coupled to liposomes at a well defined site (the thiol(s) of 
the 'hinge' region) that is remote from the antigen-recogni- 
tion site, thus avoiding perturbation of the latter and the 
158 S. Shahinian, J.R. Silvius / Biochimica et Biophysica Acta 1239 (1995) 157-167 
introduction of random amino acid modifications into the 
protein. Moreover, the absence of the antibody Fc domain 
in Fab' fragments eliminates a range of Fc-mediated bio- 
logical activities, some of which (e.g., complement activa- 
tion via the classical pathway and humoral responses or 
clearance via antibody-Fc receptor interactions [15-17]) 
may be undesirable in various applications. These advan- 
tages, coupled with the potential to produce humanized 
and otherwise modified antibody fragments by biotech- 
nological methods [18,19], may aid in the exploitation of 
antibody fragments as targeting factors while minimizing 
unwanted biological side effects (e.g., immunogenicity) of 
such molecules. 
Various methodologies have been proposed for cou- 
pling Fab' fragments to liposomes, via either thioether 
[8,20-25] or disulfide [1,26] linkages to suitable 'anchor' 
lipids. However, in applying such methodologies to couple 
a murine monoclonal Fab' fragment o liposomes, we 
encountered low and frequently irreproducible coupling 
yields, as has also been encountered in previous studies 
using similar approaches. Such complications pose a po- 
tentially significant limitation to the application of this 
promising targeting strategy, as the surface density of 
coupled antibodies has been shown to be an important 
determinant of the selectivity and avidity of liposome-cell 
binding [27-29]. 
In an effort to overcome the generally low efficiency of 
Fab'-liposome coupling, we have identified the factors that 
compromise the efficiency of this process, and we have 
developed procedures (and new liposome-coupling 
reagents) to control better and to optimize the extent of 
liposome-Fab' coupling. As a result we have identified 
conditions permitting both rabbit and mouse Fab' frag- 
ments to be coupled to liposomes with efficiencies (ca. 
65-70%) that considerably exceed those previously ob- 
served for liposomal coupling either of Fab' fragments or, 
in most previous reports, of intact immunoglobulin 
molecules. The availability of such methodologies should 
facilitate the employment of Fab' fragments as potential 
alternatives to whole (derivatized) antibodies as liposome- 
'targeting' agents in a variety of applications. 
2. Materials and methods 
Egg phosphatidylcholine (ePC) and transphosphatidy- 
lated (egg) phosphatidylethanolamine (tPE) were obtained 
from Avanti Polar Lipids (Alabaster, AL). Cholesterol was 
obtained from NuChek Prep (Elysian, MN). Egg phospha- 
tidylglycerol (ePG) was prepared by enzymatic transphos- 
phatidylation of ePC with phospholipase D as described 
previously [30]. Rhodamine-PE (Rho-PE) was prepared 
from tPE as described previously [31 ]. 
e-Maleimidocaproic a id N-hydroxysuccinimide ester 
(EMCS), /3-maleimidopropionic a id N-hydroxysucci- 
nimide ester (BMPS), rabbit non-specific IgG, pepsin and 
L-cysteine were obtained from Sigma (St. Louis, MO). 
Bio-Gel P-6DG and all electrophoresis reagents were ob- 
tained from Bio-Rad (Mississauga, Ontario). Na125I was 
obtained from ICN (Mississauga, Ontario). All cell culture 
reagents except for apotransferrin were obtained from 
Gibco Laboratories (Grand Island, NY). All other common 
chemicals and synthetic reagents were reagent grade or 
better. Calcein and carboxyfluorescein (Sigma) were puri- 
fied by chromatography on Sephadex LH-20 as described 
previously [32]. Hybridoma cells producing the murine 
TFRI (anti-human transferrin receptor) mAb [33] were 
obtained from the laboratory of Dr. R.M. Johnstone (Mc- 
Gill University) and were cultured in RPMI medium sup- 
plemented with insulin, holotransferrin (prepared from hu- 
man apotransferrin (Sigma) as described previously [34]), 
ethanolamine and sodium selenite [35]. The antibody was 
purified from culture supernatants by chromatography on
protein A-Sepharose CL-4B (Pharmacia) as described pre- 
viously [36]. 
BMP-PE was prepared by reacting tPE (100 mM in 
99:1 chloroform/triethylamine (TEA)) with 2 molar 
equivalents of BMPS (Sigma) under argon for 16 h at 
25°C, then purified by preparative thin-layer chromatog- 
raphy (TLC) on silica gel 60 plates in 75:20:5:4 chloro- 
form/methanol/acetonitrile/water [37]. EMC-PE was 
prepared similarly from EMCS (Sigma) and tPE and was 
purified by preparative TLC in 56:12.5:1:1 
chloroform/methanol/water/ammonium hydroxide. To 
prepare BMP-PEG5K, a-amino-to-methoxyPEG5K, syn- 
thesized as described previously [38], was reacted with 2 
molar equivalents of BMPS (100 mM, in 99:1 chloro- 
form/TEA) under argon for 16 h at 25°C, and the product 
was purified by preparative TLC in 90:10:1 
chloroform/methanol/water. 
a,w-Diamino-PEG1K was prepared as follows: 4 g of 
PEG1K (Sigma, further purified by the method of Honda 
[39]) was dissolved at - 10°C in 25 ml methylene chloride 
containing 6% TEA. A 4-fold molar excess of methanesul- 
fonyl chloride was then added slowly at -10°C with 
stirring. The sample was stirred at -10°C for 1 h, then 
allowed to warm slowly to 10°C and concentrated under a 
stream of nitrogen at this temperature. 8 ml concentrated 
ammonium hydroxide and 6 ml ethanol were then added, 
and the sample was sealed and incubated at 65°C for 40 h. 
The mixture was dried under nitrogen, with warming and 
repeated addition of chloroform/methanol (2:1) to aid 
water removal, and the waxy residue was redissolved in 
chloroform and purified by flash chromatography [40] on 
silica gel 60 (Merck), using 15% methanol in chloroform 
as the eluant. 
BMP-PEG1K-PE (Fig. 1) was prepared by the follow- 
ing protocol. N-Succinyl-PE was first prepared from tPE 
as described previously [41]. The product (25 mg/ml in 
dry DMF) was reacted with 4, 3, and 3 molar equivalents 
of a, to-diamino-PEG1K, HOBT, and DCCD, respectively, 
under argon for 90 min at 25°C. The product, 
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Fig. 1. Structures of maleimidylt-PE conjugates used in this study and of 
BMP-PEG5K (n= ca. 23 and ca. 114 for BMP-PEG1K-PE and BMP- 
PEG5K, respectively). 
NH2PEG1K-PE, was purified by preparative TLC in 
50:20:10:10:5 chloroform/acetone/methanol /acet ic  
ac id/water  and reacted (at 100 mM in 99:1 
chloroform/TEA) with 2 molar equivalents of BMPS 
under argon for 2.5 h at 25°C. The phosphate-positive, 
ninhydrin-negative product was purified by preparative 
TLC in 85:15:1.5 chloroform/methanol/water (Re= 
0.35). Concentrations of all phospholipid and phospho- 
lipid-conjugate stocks were assayed by the method of 
Lowry and Tinsley [42]. 
2.1. Preparation of liposomes 
Liposomes were prepared from ePC/ePG/cholesterol 
(3:1:2 molar proportions) plus small proportions of Rho-PE 
and/or PE-maleimide conjugates (specified as molar per- 
centages with respect o total lipids) as indicated in the 
text. After drying for several h under high vacuum, the 
lipids were initially vorlexed in an appropriate aqueous 
solution as specified for each type of experiment. The 
resulting dispersions were converted either to small uni- 
lamellar vesicles (SUV), by bath sonication for 10 min 
under argon, or to large unilamellar vesicles (LUV) by 
repeated freeze-thawing followed by hand extrusion 
through 0.1 /~m pore-size polycarbonate filters [43]. SUV 
and LUV samples prep~tred in this manner gave average 
diameters of ca. 30 nm and ca. 110 nm, respectively, by 
calcein-encapsulation measurements carried out similarly 
to the carboxyfluorescein-encapsulation assay of Wilschut 
et al. [45]. The predominantly unilamellar character of the 
LUV preparations was demonstrated using comparable 
vesicles in which 10% of the PC component was replaced 
by PE; the trinitrobenzenesulfonic acid labeling procedure 
of Nordlund et al. [46] showed 42-45% of the PE compo- 
nent (whose distribution in such vesicles parallels that of 
the total lipids [46]) to be exposed at the vesicles' outer 
surface. 
2.2. F(ab' ) z preparation 
F(ab') 2 fragments were prepared from rabbit nonspe- 
cific IgG (Sigma) as described previously [26] or from the 
murine IgG2a-subclass mAb TFR1 using a modification of 
previous protocols [44], as follows. Briefly, in the latter 
protocol intact antibody (2 mg/ml) was incubated with 
pepsin (60/~g/ml) in 0.1 M sodium acetate (pH 4.2) for 4 
h at 37°C. Digestion was terminated by adding 2 M "Iris 
(pH 8.8) to a final concentration of 80 mM, then centri- 
fuging (10000 ×g,  30 min, 4°C). The supernatant was 
dialyzed at 4°C against 150 mM NaC1, 20 mM phosphate, 
pH 7.0, then chromatographed on a column of Protein 
A-Sepharose CL-4B to remove any undigested IgG. A 
portion of F(ab') 2 was radioiodinated using Iodobeads 
(Pierce) as per the manufacturer's protocol. Protein con- 
centrations were determined by a modification of the 
Lowry method [47]. 
2.3. Fab' preparation 
All solutions used for Fab' production and liposome 
coupling were extensively degassed by nitrogen purging 
before use. Rabbit or mouse F(ab') 2 (5 mg/ml) was 
reduced under argon in 30 mM cysteine, 100 mM Tris, pH 
7.6, for 15 min at 37°C except where otherwise indicated. 
The solution was then diluted 2-fold with an equal volume 
of the appropriate xperimental buffer (as indicated) and 
spun through a 0.4 ml spin-column of Bio-Gel P-6DG, 
packed in a punctured 0.5 ml microfuge tube over a glass 
wool plug, that had been pretreated with BSA (40 /zg in 
20 /xl) and washed three times with buffer. 
2.4. Fab'-liposome coupling 
Freshly reduced Fab' (1 mg/ml final), including a trace 
amount of ~25I-labelled protein, was centrifuged through a 
Bio-Gel spin-column as just described into an argon-blan- 
keted sample of LUV (0.2-10 mM total lipid), normally in 
150 mM NaCI, 10 mM Mops, 0.1 mM EDTA, 50 /zM 
DTPA, pH 6.5 (final antibody concentration = 1 mg/ml). 
The mixture was then incubated under argon in a sealed 
tube for 16 h at 4°C with gentle stirring. For control 
samples, similar liposomes were preincubated with 50 mM 
cysteine (1 h, 25°C) before addition of Fab' fragments. The 
liposome-Fab' coupling reaction was quenched by the 
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addition of cysteine (0.5 mM, 15 min at 25°C), then the 
mixture was chromatographed on a column of Sepharose 
CL-4B (Pharmacia, Baie D'Urfe, QuEbec) for LUV or 
Sepharose CL-6B for SUV. Fab' was quantitated in the 
eluted fractions by gamma counting, using an LKB 1270 
Rackgamma II counter, and liposomal lipid was monitored 
by fluorescence of liposome-incorporated Rho-PE (1 
mol%), using a hand-held blacklight for qualitative obser- 
vation and a Perkin Elmer LS-5 spectrophotometer for 
quantitation. 
2.5. Fab'-PEG5K shift assay 
Freshly reduced Fab' (20 /zl at 1 mg/ml, with or 
without a trace amount of radiolabelled protein) was cen- 
trifuged as above through a Bio-Gel spin-column into an 
equal volume of BMP-PEG5K (500 /zM, in pH 6.5 buffer 
as above) and allowed to react under argon for 1 h at 25°C. 
The reaction was quenched by the addition of NEM (25 
mM, 25°C, 30 min). The samples were then analyzed by 
non-reducing SDS-PAGE [48], using a 12% resolving el, 
and were visualized by coomassie blue staining and/or 
autoradiography. Quantitation of protein bands was per- 
formed by densitometry using a Fujix BAS 2000 imaging 
system. 
2.6. Leakage assay 
LUV, prepared as described above in isotonic (100 
mM) calcein, pH 7.4 were gel-filtered on Sepharose CL-4B 
(buffer = 150 mM NaCI, 10 mM Tes, 0.1 mM EDTA, pH 
7.4) at 4°C to remove unencapsulated dye. After incuba- 
tion under various conditions as indicated in the text, 
aliquots of the calcein-loaded LUV were withdrawn and 
analyzed for fluorescence ( xcitation and emission wave- 
lengths 490 and 520 nm, respectively) on a Perkin Elmer 
LS-5 spectrophotometer b fore and after the addition of 
Triton X-100 to 1% (w/v). The percentage of calcein 
retained in the liposomes was calculated from the extent of 
fluorescence dequenching upon Triton addition [44,49,50], 
assuming 100% encapsulation of the dye in liposomes 
freshly eluted from the Sepharose column. 
2.7. Fluorescence microscopy 
LUV, prepared in 45 mM carboxyfluorescein, 10 mM 
Mops, 0.1 mM EDTA, pH 6.5 that was adjusted to iso- 
tonicity (270 mosM) with NaCI, were coupled to Fab' 
fragments (10 mM lipid, 1 mg/ml Fab') as described 
above but using the carboxyfluorescein-containing buffer 
just noted. The sample was then adjusted with NaOH to 
pH 7.4, and the mixture was allowed to equilibrate for 1 h 
at 25°C, then gel-filtered on Sepharose CL-4B to remove 
unencapsulated dye. CV-1 cells, grown on glass coverslips 
to approx. 75% confluency, were washed once and then 
incubated for 1 h at 37°C in serum-free medium, then 
washed twice with Hanks' buffered saline solution includ- 
ing 10 mM Hepes (HBSS/Hepes) and cooled to 4°C. To 
reduce nonspecific binding of liposomes, cells were nor- 
mally preincubated with PC/PG/cholesterol SUV (50 
/~M in HBSS/Hepes) for 15 rain at 4°C. The cells were 
washed twice with cold HBSS/Hepes, then incubated for 
30 min at 4°C with Fab'- or cysteine-coupled LUV (40 
/zm lipid, 1 ml per coverslip) in HBSS/Hepes. After the 
liposome-cell incubation, the cells were washed twice with 
serum-free medium and incubated at 37 ° for I h, then 
washed with HBSS/Hepes and observed using a Zeiss 
epifluorescence microscope. Kodak TMY400 film was 
used for photography. 
3. Results 
In initial experiments, the murine mAb TFRI (IgG2a 
subclass) was converted to Fab' fragments, using cysteine 
as the reducing agent [51 ], and coupled to large unilamellar 
liposomes containing 2.5 mol% of the maleimide-deriva- 
tized lipid EMC-PE [13,52]. To obtain an optimal yield of 
Fab' fragments as assessed by nonreducing SDS-PAGE, 
we initially reduced F(ab') 2 fragments using 10 mM cys- 
teine, pH 7.6 for 45 min at 37°C. Considerably lower 
yields of Fab' fragments (typically < 35%) were obtained, 
under separately optimized conditions, using DTT or /3- 
mercaptoethanol as alternative reducing agents (results not 
shown). However, while the yield of Fab' fragments ob- 
tained using the 'optimal' cysteine-reduction conditions 
described above typically exceeded 75%, only a low and 
variable fraction of the Fab' fragments (2% to 13% in 21 
experiments) could be coupled to EMC-PE-containing 
LUV. LUV containing different thiol-reactive lipid 
'anchors' (BMP-PE, BMP-PEG1K-PE (see Fig. l) or 
PDP-PE) showed modest differences but in no case any 
pronounced improvement in the efficiency of Fab'-lipo- 
some coupling (maximum yield < 20%), which moreover 
remained highly variable. Similar results were obtained in 
experiments u ing SUV in place of LUV or increasing to 5 
mol% the proportion of the thiol-reactive lipid 'anchor' in 
the liposomes. Similarly low efficiencies of coupling of 
Fab' fragments to liposomes (typically < 30%) have been 
reported by other workers [1,8,20-24,26]. 
The observations noted above suggested a clear need to 
better define (and thereby to optimize) the factors govern- 
ing Fab'-liposome conjugation. A key question was whether 
the extent of Fab'-liposome coupling was limited by some 
property of the Fab' preparation itself or rather by an 
inherent feature of the liposome-Fab' conjugation process 
(e.g., kinetic competition between liposomal coupling and 
reoxidation of maleimide-reactive sulfhydryl groups). To 
address this question, we devised an assay, using a 
maleimide-bearing derivative of PEG-5000 (BMP-PEG5K 
(see Fig. 1)), to determine quantitatively the proportion of 
Fab' fragments in a given preparation that bears reactive 
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sulfhydryl residues. As shown in Fig. 2, coupling of 
BMP-PEG5K to mouse Fab' sulfhydryl groups substan- 
tially altered the mobility of the Fab' fragments upon 
(nonreducing) SDS-PAGE analysis, allowing ready quanti- 
tation of the proportions of maleimide-reactive Fab' frag- 
ments (upper arrow) and nonreactive Fab' fragments (lower 
arrow) by gel-scanning densitometry. A lower molecular 
weight maleimidyl-PEG conjugate, BMP-PEG2K, shifted 
essentially the identical proportion of Fab' fragments in 
parallel reactions, although as expected by a smaller dis- 
tance (not shown). These shifts were in all cases com- 
pletely blocked by prior treatment of the Fab' fragments 
with NEM (Fig. 2, compare lanes 1 and 2). Reducing 
SDS-PAGE analysis of B/VIP-PEG5K-reacted Fab' showed 
that only the heavy chain was shifted by the maleimidyl- 
PEG (not shown), consistent with the expected selective 
reaction of this reagent with the reduced 'hinge'-region 
sulfhydryl(s) of the Fab' fragments [51]. In preliminary 
experiments we found that even a modest molar excess 
(5-fold) of BMP-PEG5K over Fab' was sufficient o shift 
the maximal fraction of Fab' fragments in a given prepara- 
tion. However, a 25-fold molar excess of BMP-PEG5K 
was routinely used to ensure maximal derivatization of 
Fab' sulfhydryl groups in all cases. 
Using the assay just described, we found that Fab' 
preparations obtained using different reduction conditions 
varied widely in their contents of maleimide-reactive mate- 
rial, even when all preparations contained high proportions 
of 55 kDa (apparent molecular mass) Fab' fragments as 
assessed by conventional (non-reducing) SDS-PAGE anal- 
ysis. As illustrated in Fig. 2 (lanes 2-4), during extended 
incubation of F(ab') 2 fragments with either cysteine or 
(not shown) mercaptoethylamine th re is a gradual and 
pronounced ecline in the proportion of Fab' fragments 
that is maleimide-reactive (band denoted by upper arrow), 
although the proportion of total Fab' fragments decreases 
only modestly with increasing time of incubation. As a 
result, the conditions initially developed to optimize the 
production of Fab' fragments as assessed by conventional 
SDS-PAGE analysis (10 mM cysteine, pH 7.6, 37°C, 45 
min) prove to yield only a low proportion of maleimide-re- 
active Fab' (Fig. 2, lane 3). An analogous, though some- 
what slower time-dependent loss of maleimide-reactive 
Fab' fragments was also detected in the reduction of rabbit 
IgG-derived F(ab') 2 under similar conditions (not shown). 
For both F(ab') 2 species, it was possible to identify modi- 
fied incubation conditions (employing shorter incubations 
and higher cysteine concentrations) that afford high yields 
of reactive sulfhydryl-bearing Fab' fragments (60-80% 
based on total input protein) while increasing only mini- 
mally the extent of overreduction f Fab' to isolated heavy 
and light chains. 
The results just presented suggested that using conven- 
tionally 'optimized' protocols for Fab' production, the 
efficiency of subsequent iiposome-Fab' coupling can be 
limited most fundamentally by inefficient production of 
maleimide-reactive Fab' fragments. This suggestion was 
supported by a comparison of the efficiency of coupling of 
antibody TFR1 Fab' fragments, prepared using a re-opti- 
mized reduction protocol as just described (30 mM cys- 
teine, pH 7.6, 15 min at 37°C), to either BMP-PEG5K or 
SUV containing 2.5 mol% BMP-PEG1K-PE. In a repre- 
sentative xperiment, a preparation of Fab' fragments con- 
taining 78% of reactive sulfhydryl-bearing Fab' (assessed 
Cys (mM) 10 mM 
I I 
Reduction (NEM) 
t ime(min.)  15 15 45 180 
30 mM 
I I 
15 45 180 
- -  200 
- -  97.4 
- -  66 
- -  45  
- -31  
- -  21.5 
Fig. 2. Representative non-reducing SDS-PAGE results using the BMP-PEG5K 'shift assay' for various preparations of TFRI-Fab' fragments. Lane l: 
mAb TFRl-derived F(ab') 2 was incubated with 10 mM cysteine (37°C, pH 7.6) for 15 min, then rapidly gel-filtered and reacted with NEM (50 mM, 30 
min at 25°C). Lanes 2-4: F(ab') 2 was incubated with 10 mM cysteine for 15 min, 45 min or 180 min, respectively, then gel-filtered and reacted 
successively with BMP-PEG5K (0.5 mM, 60 min at 25°C) and with 50 mM NEM. Lanes 5-7: as for lanes 2-4, but using 30 mM cysteine in the initial 
incubation. Other experimental conditions were as described in Section 2. The upper and lower arrows denote the positions of migration of 
BMP-PEG5K-reacted Fab' and of unreacted Fab' (observed as a doublet due to alternate sites of pepsin cleavage), respectively. For reference, the 
uppermost (ca. 121 kDa) band in lane 1 represents intact F(ab') 2 fragments, and the lowest wo bands represent heavy chain fragments (ca. 26 kDa, seen as 
a doublet in some lanes) and light chains (ca. 23 kDa) released by Fab' overreduction. 
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Table 1 
Summary of Fab'-liposome coupling using maleimide-PE linkers 
Maleimide-PE Type of mol% Number of % Fab' mol Fab'/ 
linker liposome linker samples tested bound mol linker 
EMC-PE 
BMP-PE 
BMP-PEG 1K-PE 
BMP-PEG 1K-PE + rabbit Fab' 
LUV 0.5 2 28.4 -t- 0.4 0.074 + 0.002 
LUV 0.5 6 30.6 ___ 2.0 0.081 -t- 0.007 
2.5 4 51.4 + 9.4 0.029 ___ 0.007 
SUV 0.5 2 25.8 -t- 0.9 0.078 + 0.003 
2.5 4 56.1 -I- 1.2 0.039 ___ 0.002 
LUV 0.5 6 56.1 + 2.5 0.166 + 0.009 
2.5 4 63.9 -I- 7.2 0.037 + 0.005 
SUV 0.5 2 55.3 -I- 1.3 0.166 + 0.009 
2.5 8 70.6 ___ 1.9 0.046 ___ 0.002 
SUV 2.5 2 64.3 -t- 0.2 0.049 + 0.002 
Freshly reduced Fab' (1 mg/ml final concentration) was coupled to ePC/ePG/cholesterol (3:1:2 molar proportions) liposomes incorporating the indicated 
molar percentages of different maleimidyl lipids (10 mM total ipid). Conditions of the coupling reactions were as specified in Section 2. Tabulated values 
represent means + 1 S.D. 
by BMP-PEG5K conjugation 1) showed 76% coupling to 
the vesicles at lipid and Fab' concentrations of 10 mM and 
1 mg/ml ,  respectively. The similarity of these two values 
indicates that a very high proportion of the maleimide-re- 
active Fab' fragments in the preparation can readily be 
coupled to l iposomes under these conditions. There thus 
appears to be no intrinsic l imitation to the efficiency of 
coupling of free sult'hydryl-bearing Fab' fragments to ap- 
propriately derivatized l iposomes under coupling condi- 
tions like those just described. 
The results described above do not rule out the possibil- 
ity that factors other than the availability of free 
sulfhydryl-bearing Fab' fragments may affect the effi- 
ciency of Fab'- l iposome coupling under certain conditions. 
Different applications of Fab'-targeted l iposomes may dic- 
tate the use of l iposomes of different sizes, compositions 
and/or  degrees of surface modification. Accordingly, we 
examined the efficiency of coupling of Fab' fragments to 
both LUV and SUV containing either the conventional 
maleimidyl ipids BMP-PE and EMC-PE or a novel lipid 
'anchor' ,  BMP-PEG1K-PE,  which incorporates a PEG 
spacer between the lipid and maleimide groups. Spacer- 
containing lipid 'anchors'  like BMP-PEG-PEs will l ikely 
be required to achieve efficient coupling of Fab' fragments 
to l iposomes that bear surface-anchored polymers as steric 
masking agents to reduce the rate of l iposomal clearance in 
vivo [10,53-58]. 
i The weight fraction of maleimide-reactive Fab' in a given sample (as 
a fraction of total protein mass) was estimated from the Coomassie 
staining intensity of the BMP-PEG-shifted band, expressed as a fraction 
of the total staining intensity measured for all protein bands in the same 
sample. This calculation rests on two assumptions: first, that reduction of 
a given mass of F(ab') 2 to Fab' (or to light chains and heavy-chain 
fragments) does not substantially alter the total Coomassie-staining i ten- 
sity summed over all of the product bands, and second, that the addition 
of PEG chains to Fab' fragments does not significantly alter their 
Coomassie-staining tensity. Both assumptions were supported by the 
results of control experiments designed to test these points. 
In Fig. 3 are shown representative r sults illustrating the 
dependence of the Fab' coupling efficiency on the lipid 
concentration for LUV differing in their content and type 
of maleimidyl- l ipid 'anchor. '  It is clear that higher concen- 
trations of l iposomes promote greater efficiency of Fab' 
coupling, even though in these experiments the liposome- 
bound maleimidyl groups are in all cases far from satu- 
rated by coupled Fab' fragments (see Table 1). Liposomes 
incorporating a lower molar percentage of maleimidyl- l ipid 
100 
80 
6o 
4o 
20 
0 2 4 6 8 10 12 
[Lipid] (mM) 
Fig. 3. Lipid concentration dependence of the coupling of TFRI Fab' 
fragments (1 mg/ml) to PC/PG/cholesterol/Rho-PE (3:1:2:0.06 molar 
proportions) LUV containing 0.5 mol% BMP-PE (O), 0.5 mol% BMP- 
PEG1K-PE (O), 2.5 mol% BMP-PE (D) or 2.5 mol% BMP-PEG1K-PE 
(ll). Coupling reactions were carried out as described in Section 2. Error 
bars represent the range of values measured for duplicate samples incu- 
bated at each lipid concentration. 
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(0.5 mol% vs. 2.5 mol%) must be present at higher 
concentrations to maximize the fraction of Fab' that be- 
comes liposome-bound. Interestingly, however, replace- 
ment of BMP-PE by the spacer-containing BMP-PEG1K- 10o 
PE significantly enhance~ the efficiency of liposome-Fab' 
coupling at lower lipid concentrations, particularly when 
using a low proportion (0.5 mol%) of the maleimidyl-lipid 95 
'anchor'. 
In Table 1 are summmized the results of a number of -~ 
experiments to measure the effects of liposome size (ca. 30 ~ 90 
nm. vs. 110 nm. average diameter), and of the content and 
type of maleimidyl-lipid 'anchor', on the efficiency of 
Fab'-liposome coupling at a fixed lipid concentration (10 t~ 85 
mM). These experiments; were carried out using prepara- .=_ 
tions of Fab' fragments containing 60% to 78% (weight 
fraction of total protein) of reactive sulfhydryl-bearing Fab' O 80 
fragments as assessed by the gel-shift assay described *~ 
above. Several points are evident. First, using 2.5 mol% 
maleimidyl-lipid in either SUV or LUV, it is possible 75 
reproducibly to achieve coupling of a very high proportion 
of the reactive sulfhydr.¢l-bearing Fab' fragments to the 
liposomes, particularly using liposomes incorporating 70 
BMP-PEG1K-PE. Second, only minor reductions in cou- 0 
piing yield are observed using as little as 0.5 mol% of 
BMP-PEGIK-PE in the liposomes. By contrast, for lipo- 
somes containing the more conventional maleimidyl-lipids 100 
BMP-PE and EMC-PE, reduction in the content of 
maleimidyl lipid from 2.5 mol% to 0.5 mol% considerably as 
reduces the efficiency of Fab' coupling. Third, as the 
standard deviations in Table 1 demonstrate, procedures 
optimized specifically for the production of free _~ 90 
sulfhydryl-bearing Fab' fragments afford very good repro- 
ducibility as well as efficiency of liposome-Fab' coupling. 
Finally, as shown by tlhe final entry in Table 1, high t~ a5 
efficiencies of liposomal coupling of rabbit polyclonal as .__. 
well as mouse monoclonal Fab' fragments can be achieved 
using the coupling protocols and lipid 'anchors' described ~ 80 
here. .~ 
To monitor the effects of liposome-incorporated 
maleimidyl-lipids and of bound Fab' fragments on reten- 7s 
tion of liposomal conten~Is, two types of experiments were 
carried out. First, liposomes were prepared containing 
calcein at a high, self-quenching concentration (100 mM), 70 
and retention of calcein at 37°C was measured by a o 
fluorescence-dequenching assay [45,49,50] as a function of 
the liposomal content of different maleimidyl-lipids and of 
the presence of bound Fab' fragments. Representative data 
from such experiments ~xe shown in Fig. 4. As shown in 
Fig. 4A, control l iposomes prepared without any 
maleimidyl-lipid component lose roughly 12% of en- 
trapped calcein after 24 h of incubation at 37°C. Under the 
same conditions liposomes incorporating 2.5 mol% of 
EMC-PE or BMP-PE show similar losses of encapsulated 
contents after 24 h incubation while liposomes incorporat- 
ing 2.5 mol% of BMP-PEG1K-PE release a slightly greater 
fraction of their contents, mainly within the first few hours 
A 
' ' ' I I . . . .  I . . . .  I , , . | | I n I n 
5 1 0 15 20 25 
T ime (hrs) 
T 
B 
. . . .  1 . . . .  I . . . .  I . . . .  I l l l l  
5 1 0 15 20 25 
Time (hrs) 
Fig. 4. Effect of maleimidyl-functionalized PEs on liposomal stability as 
determined byretention of encapsulated calcein. (A) PC/PG/cholesterol 
(3:1:2) LUVs, containing no maleimidyl-lipid (©), 2.5 mol% of either 
EMC-PE (O), BMP-PE ([2]) or BMP-PEG1K-PE (11), or 2.5 mol% 
BMP-PEG1K-PE coupled to TFR1 Fab' fragments (ix), were incubated 
at 37°C. Calcein retention at the indicated time points was determined and 
liposome-Fab' coupling carried out as described in Section 2. (B) 
PC/PG/cholesterol LUVs containing 0 mol% (©), 0.5 mol% (O), 1.0 
mol% (D) or 2.5 mol% (ll) BMP-PEG1K-PE were incubated for 
varying times before determining the percentage encapsulation f calcein 
as above. Error bars represent the range of values measured for duplicate 
samples independently incubated for the indicated times. 
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of incubation, after which further leakage slows markedly. 
As illustrated in Fig. 4B, less leakage of entrapped calcein 
is seen for liposomes incorporating lower mol fractions of 
maleimidyl-lipid (in this figure, BMP-PEG1K-PE). The 
presence of coupled Fab' fragments did not significantly 
affect the rate of calcein leakage from liposomes contain- 
ing 2.5 mol% BMP-PEG1K-PE (Fig. 4A, open triangles). 
In a second series of experiments, we examined the 
retention of calcein in iiposomes during the process of Fab' 
coupling at 4°C; Bredehorst et al. [21] have reported very 
substantial losses of liposomal contents during coupling of 
Fab' fragments to liposomes containing a different 
maleimidyl-lipid 'anchor'. Calcein-loaded LUV (1 mM) 
containing different proportions of either BMP-PE or 
BMP-PEG1K-PE were incubated at 4°C with Fab' frag- 
ments (1 mg/ml),  then treated with cysteine to quench 
excess liposome-associated maleimidyl groups, using the 
same conditions as in our standard liposome-Fab' coupling 
protocol. In a representative experiment, after coupling to 
Fab' fragments (1 mg/ml)  for 16 h at 4°C, liposomes 
containing 0.5 mol% or 2.5 mol% BMP-PE retained 91% 
and 84% of their originally entrapped calcein, respectively, 
while similar liposomes containing BMP-PEGIK-PE re- 
tained 89% and 85%, respectively. After subsequent 
quenching with 0.5 mM cysteine (15 min at 4°C), lipo- 
somes containing 0.5 mol% or 2.5 mol% BMP-PE retained 
Fig. 5. Fluorescence microscopy of CV-1 cells incubated at 37°C with TFR1 FAD'- or cysteine-conjugated PC/PG/cholesterol/BMP-PEGIK-PE 
(3:1:2:0.015) LUV loaded with carboxyfluorescein (45 mM). (A) Fah'-conjugated liposomes (40 /zM lipid) in the absence of free (TFR1) mAb. (B) 
Fab'-conjugated liposomes in the presence of 1 mg/ml free mAb. (C) Cysteine-conjugated ('untargeted') liposomes inthe absence offree mAb. (D-F) 
Phase-contrast images of the fields hown in panels A-C. Details of sample preparation, liposome-cell incubations and fluorescence microscopy are given 
in Section 2. 
s. Shahinian, J.R. Silvius / Biochimica et Biophysica Acta 1239 (1995) 157-167 165 
91% and 74% of their original (pre-Fab'-incubation) cal- 
cein content, respectively, while similar liposomes contain- 
ing 0.5 mol% or 2.5 mol% BMP-PEG1K-PE retained 77% 
and 66%, respectively. Control liposomes lacking 
maleimidyl-lipid retained 96% of initially encapsulated 
calcein after the initial 4°C incubation with Fab' fragments 
and showed negligible further calcein release upon subse- 
quent incubation with cysteine. As noted above, once 
coupled to Fab' fragments liposomes howed very slow 
rates of leakage (< 0.4%/h) upon subsequent incubation 
at 37°C. 
To confirm that Fab'-coupled liposomes prepared in the 
manner described here are functionally competent to rec- 
ognize the 'targeted' cell-surface determinant(s), weexam- 
ined the uptake by CV-1 cells of carboxyfluorescein (CF)- 
loaded vesicles conjugated to TFR1 Fab' fragments, which 
recognize the extracellular domain of the transferrin recep- 
tor [33]. CF-loaded LUV containing 2.5 mol% BMP- 
PEG1K-PE were conjugated either to TFR1 Fab' frag- 
ments or to cysteine, and the liposomes thus derivatized 
were incubated for 1 h at 37°C with CV-1 cells, which 
were subsequently washed and examined by fluorescence 
microscopy. As shown in Fig. 5 (panels A/D), cells 
incubated with the Fab'-conjugated liposomes how a dif- 
fuse intracellular fluorescence which is due to endocytic 
uptake of the liposomes and subsequent diffusion of the 
protonated ye from the acidic endosomal lumen to the 
cytoplasm [49]. By contrast, cells incubated with TFR1 
antibody (1 mg/ml) but not with an irrelevant antibody 
(not shown) before and during incubation with the Fab'- 
conjugated liposomes (panels B/E) show greatly reduced 
endocytic uptake of carboxyfluorescein. Similarly, non- 
Fab'-coupled ('untargeted') liposomes, treated with cys- 
teine to block reactive maleimidyl groups [24] (panels 
C/F), show very low levels of endocytic uptake under the 
above incubation conditions. The results shown in Fig. 5 
were obtained using cells preincubated with 
ePC/ePG/cholesterol SUV (50 /~M), to reduce nonspe- 
cific binding of liposomes. A qualitatively similar pattern 
of results was observed using cells that were not pretreated 
with SUV (not shown), but in this case higher nonspecific 
uptake of carboxyfluorescein was observed using untar- 
geted liposomes or targeted liposomes in the presence of 
blocking antibody. Interestingly, in the absence of SUV 
pretreatment the nonspecific binding of liposomes incorpo- 
rating BMP-PEG1K-PE (with or without bound Fab') was 
much less than that of similar liposomes lacking this lipid 
'anchor.' This result is likely attributable to steric interfer- 
ence by liposome-bound PEG groups with nonspecific 
interactions between the liposome and cell surfaces. 
4. Discussion 
While the strategy of coupling Fab' fragments to lipo- 
somes via their exposed 'hinge' thiols was first introduced 
in the early 1980s [20,26], this approach has achieved 
relatively limited use in practice, due in part to the low and 
variable coupling yields that may be achieved. Dithio- 
threitol reduction typically gives substantial over-reduction 
under conditions in which a majority of F(ab') 2 is cleaved, 
severely complicating efforts to obtain high and repro- 
ducible yields of Fab' fragments by this approach ([59]; 
and present results (not shown)). The use of monovalent 
thiol compounds as reducing agents greatly diminishes this 
problem but, as we have shown here, can still entail a 
more insidious one, namely the formation of appreciable 
amounts of 'non-couplable' Fab' fragments under condi- 
tions where Fab' production appears optimal by conven- 
tional SDS-PAGE analysis. Using the maleimidyl-PEG 
'shift' assay to detect and to minimize this latter problem, 
conditions can be determined that routinely afford high 
efficiencies of liposome-Fab' coupling, equivalent to up to 
ca. 70% of input F(ab') 2 protein and to virtually 100% of 
the reactive sulfhydryl-containing Fab' fraction in a given 
preparation. 
The phenomenon of gradual and substantial formation 
of 'non-couplable' Fab' fragments during reduction of 
F(ab') 2 with thiols such as cysteine or cysteamine has to 
our knowledge not hitherto been described, perhaps due to 
the previous absence of a direct assay for the formation of 
such species. In our view the most likely explanation for 
this phenomenon is a gradual reoxidation of the reduced 
hinge thiol(s) of freshly generated Fab' fragments, to form 
either Fab'-cyste(am)ine mixed disulfides or, potentially, 
an intrachain disulfide bond in Fab' fragments containing 
two reduced sulfhydryl groups. Such disulfides may form 
much more readily than do F(ab') 2 fragments, explaining 
the fact that the gradual appearance of 'non-couplable' 
Fab' during prolonged treatment with monovalent thiols is 
accompanied by only modest reformation of F(ab') 2. 
The maleimidyl-PEG-based 'shift assay' described here 
provides a convenient means to optimize conditions for 
production of Fab' fragments bearing reactive sulfhydryl 
groups, as is required to prepare Fab'-containing conju- 
gates with liposomes, toxins and other agents. The 
maleimidyl-PEG reagent, which can readily be prepared 
from commercially available a-amino-to-methoxy-PEG5K 
and BMPS, efficiently and rapidly derivatizes Fab' thiol 
groups when present at relatively low concentrations and 
in only a modest molar excess over the Fab' fragments. A 
sample of an Fab' preparation can be derivatized and 
electrophoretically analyzed within as little as two hours 
(during which time Fab' fragments can be stabilized by 
cold and reduced pH [51]), in principle allowing the pro- 
portion of maleimide-reactive Fab' in a given preparation 
to be determined before liposomal coupling in applications 
where very fine control of coupled-Fab' density is critical. 
For most purposes, however, as the results hown in Table 
1 indicate, very good reproducibility of Fab'-liposome 
coupling can be achieved simply by using a standard 
optimized protocol for Fab' production and well-controlled 
conditions for the coupling reaction. 
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The maleimide-based coupling of Fab' fragments to 
liposomes containing an already-encapsulated solute has 
been reported to induce severe leakage of liposome-en- 
capsulated molecules [21]. Coupling of Fab' fragments to 
liposomes incorporating the maleimidyl-PE 'anchors' ex- 
amined here induced comparatively modest, albeit signifi- 
cant, losses of encapsulated contents pecifically during 
the coupling and cysteine-quenching steps. As observed 
previously, the presence of liposome-coupled Fab' frag- 
ments has very little effect on retention of liposomal 
contents after the initial coupling is complete. For optimal 
encapsulation f solutes using the protocols described here, 
liposome-Fab' coupling should thus ideally be performed 
with the solute present inside and outside the vesicles; 
unbound antibody and (where necessary) unencapsulated 
solute could then be removed together upon subsequent 
gel-filtration. Where this approach is not feasible, how- 
ever, using appropriate levels of the maleimidyl-lipids 
described here, Fab' fragments can still be coupled to 
liposomes in good yields and with acceptable (> 75%) 
retention of contents throughout the entire coupling proce- 
dure. 
The novel PE-PEG-maleimide 'anchor' lipid employed 
here, BMP-PEG1K-PE, is analogous to a number of other 
functionalized PE-PEG's that have been described recently 
[11,12,58,60,61] and offers at least two potential advan- 
tages over previously described maleimidyl-lipids with 
shorter spacers between the lipid and maleimidyl moieties. 
First, proteins coupled to functionalized lipids containing 
PEG spacers typically retain good reactivity with cell- 
surface recognition determinants when incorporated into 
liposomes containing other PEG-modified lipids as steric 
masking agents [11,12,58,61]. This is not true for proteins 
coupled to lipid 'anchors' containing shorter spacer groups 
when incorporated in similar sterically 'masked' liposomes 
[10,53,61]. Second, as we have shown here, the extended 
spacer in BMP-PEG1K-PE permits more efficient coupling 
of Fab' groups to liposomes, particularly at suboptimal 
lipid concentrations and at even low (0.5 mol%) mole 
fractions of the incorporated maleimidyl-lipid 'anchor'. 
This finding likely reflects an enhanced steric accessibility 
of maleimidyl groups to reactive Fab' fragments when the 
maleimidyl groups are tethered to the liposome surface via 
a long, flexible PEG 'spacer'. 
The efficiencies of liposome-Fab' coupling routinely 
observed using the approach described here (ca. 70% of 
input protein for liposomes containing BMP-PEG1K-PE) 
are considerably better than those reported previously for 
Fab' fragments (typically < 30% [1,8,20-23,26]) and are 
in fact comparable to the best liposomal coupling yields 
reported, using any coupling methodology, for whole anti- 
bodies. Since virtually 100% of free sulfhydryl-bearing 
Fab' fragments can be coupled to liposomes using the 
conditions described here, it is possible that further im- 
provements in the efficiency of production of such frag- 
ments could improve overall Fab'-liposome coupling effi- 
ciencies till further. Fab' fragments offer potentially sig- 
nificant advantages over intact antibodies for certain appli- 
cations, e.g., to avoid a variety of biological responses 
mediated by the antibody Fc region [16,17,62]. The results 
reported here should facilitate the wider use of Fab' frag- 
ments for liposomal targeting in such cases. 
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